Live feed06:40:00·9dNEWSReleasevia QuantisnowPrecigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study EncouragingByQuantisnow·Wall Street's wire, on your screen.PGEN· Precigen Inc.Health Care
